🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

RecruitingNAAges 18 Years - anyAllInstitute of Tropical Medicine, Belgium
NCT06981442 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health. In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited. In the Democratic Republic of the Congo (DRC), several epidemics of yellow fever, dengue fever, chikungunya and Zika cases have been reported. In particular, in Kinshasa, the dengue and chikungunya viruses have previously been detected in patients with undifferentiated fevers and several studies have shown entomological transmission indices above the criteria and standards of the World Health Organization (WHO). The aim of our study is to implement and evaluate different strategies to control Aedes mosquitoes at different stages of their life cycle in

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
At household level: Inclusion Criteria: * Belong to a household in one of the 4 health areas selected as study arms * From 18 years of age to consent for household enrollment and participation in the serosurvey * Consenting Exclusion Criteria: * Not belong to a household in one of the 4 health areas selected as study arms * Under 18 years of age * Non-consenting At health facility level: Inclusion Criteria: * From 18 years of age * Resident of the health zone of Mont Ngafula 1 * Consenting Exclusion Criteria: * Under 18 years of age * Not resident in the health zone of Mont Ngafula 1 * Seriously ill and hospitalized, requiring transfusion, presence of blood clotting disorders, allergies resulting from injections, adverse events associated with previous blood sampling, pregnancy * Non-consenting
💊

What it tests

  • Community-based environmental management
  • Vector control against immature stages of Aedes
  • Vector control against the mature stages of Aedes
📍

Where

1 site
Institut National de Recherche Biomédicale, INRB
Kinshasa, Democratic Republic of the Congo
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy